What’s the value in screening programmes for rare diseases?

27 August 2016 (16:40 - 16:55)

Organised by:

About the speaker

Associate Professor Jean-Claude Lubanda

Charles University of Prague, Prague (Czechia)

5 More presentations in this session

Presentation thumbnail

Welcome and introduction: identifying Fabry disease patients through cardiac manifestations. Guess who – Can you spot a rare disease patient?

Professor A. Linhart (Prague, CZ) Professor P. Elliott (London, GB)

Presentation thumbnail

Using ESC Guidelines in clinical practice to identify patients with Fabry disease.

Professor P. Elliott (London, GB)

Presentation thumbnail

Guess Who – Can you spot the Fabry disease patient? Putting guidelines into practice through delegate interactivity.

Professor A. Linhart (Prague, CZ)

Presentation thumbnail

Ten years of ERT: long-term treatment outcomes in Fabry disease.

Professor A. Linhart (Prague, CZ)

Presentation thumbnail

Q&A: identifying Fabry disease patients through cardiac manifestations. Guess who – Can you spot a rare disease patient?

Access the full session

Session thumbnail

Identifying Fabry disease patients through cardiac manifestations. Guess who – Can you spot a rare disease patient?

The Event

ESC Congress 2016

27 August 2016 16:40 CET

You may be interested in

Congress Presentation

LipoaScreen – cascade screening for lipoprotein(a)

1 September 2025

Congress Presentation

High prevalence of familial and genetic disease in children with cardiomyopathies: Baseline paediatric data from the ESC EORP Cardiomyopathy and Myocarditis Registry

29 August 2020

Congress Presentation

Preventing premature deaths through polygenic risk scores

30 August 2025

Congress Session

Late-breaking science: diagnostic methods and assessment

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources